Serotonin and Severe Affective Disorders

References

• Ashcroft G. W., Sharman D. F. Drug induced changes in the concentration of 5-OR indolyl compounds in cerebro-spinal fluid and caudate nucleus. Brit. J. Pharmacol. 1962; 19: 153
   Google Scholar
• Bourne H., Bunney W. E., Colbourn R. W., Davis J. M., Davis J. N., Shaw D. M., Coppen A. J. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet 1968; 2: 805
   PubMed Web of Science ®Google Scholar
• Bowers M. B. 5-HT metabolism in psychiatric syndromes. Lancet 1970; 2: 1029
   PubMedGoogle Scholar
• Brodie B. B., Reid W. D. Serotonin in brain; functional considerations. Recent Advances in Pharmacology, S. Garattini, P. A. Shore. Academic Press, New York 1968; Vol. 6
   Google Scholar
• Brodie B. B., Shore P. A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann. N.Y. Acad. Sci. 1957; 66: 631
   PubMed Web of Science ®Google Scholar
• Bunney W. E., Janowsky D. S., Goodwin F. K., Davis J. M., Brodie H. K. H., Murphy D. L., Chase T. N. Effect of l-dopa on depression. Lancet 1969; 1: 885
   PubMedGoogle Scholar
• Carlsson A. Functional changes of druginduced changes in brain monamine levels. Biogenic Amines, W. S. Himwich, W. A. Himwich. Elsevier, Amsterdam 1964
   Google Scholar
• Carlsson A. Drugs which block the storage of 5-HT and related amines. Handbuch der Experimentellen Pharmakologie. Vol. 19. 5-Hydroxytryptamine and related Indolealkylamines, O. Eichler, A. Farah. Springer-Verlag, Berlin 1966
   Google Scholar
• Carlsson A. Recent Advances in Pharmacology, S. Garattini, P. A. Shore. Academic Press, New York 1968; Vol. 6
   Google Scholar
• Carlsson A., Jonasson J., Lindquist M., Fuxe K. Demonstration of extraneuronal 5-HT accumulation in brain following membrane and pump blockade by chlorimipramine. Brain Research 1969; 12: 456
   PubMedGoogle Scholar
• Carroll B. J., Davies B., Mowbray R. A sequential comparison of L-TPN with ECT in severe depression. Lancet 1970; 1: 967
   PubMedGoogle Scholar
• Coppen A. J., Shaw D. M., Herzberg B., Maggs R. Tryptophan in the treatment of depression. Lancet 1967; 2: 1178
   PubMed Web of Science ®Google Scholar
• Costa G. The role of serotonin in neurobiology. International Review of Neurobiology, C. C. Pfeiffer, J. R. Smythies. Academic Press, New York 1960
   Google Scholar
• Dewhurst W. G. On the chemical basis of mood. J. psychosom. Res. 1965; 9: 115
   PubMedGoogle Scholar
• Dewhurst W. G. New theory of central amine function and its clinical application. Nature 1968; 218: 1130
   PubMed Web of Science ®Google Scholar
• Dewhurst W. G. Amines and abnormal mood. Proc. roy. Soc. Med. 1970; 62: 1102
   Google Scholar
• Dowson J. H. The significance of brain amine concentrations. Lancet 1969; 2: 596
   PubMedGoogle Scholar
• Garattini S., Valzelli L. Psychotropic Drugs, S. Garattini, V. Ghetti. Elsevier, Amsterdam 1957
   Google Scholar
• Heller B., Narasimhachar N., Haskovec J., Spaide L., Himwich H. E. N-dimethylated indoleamines in blood of acute schizophrenics. Experientia 1970; 26: 503, 1970
   PubMedGoogle Scholar
• Kore J., Valkenburgh-Sikkima T. Fluorometric determinations of 5-HIAA in human urine and cerebro-spinal fluid. Clin. Chim. Acta 1968; 26: 301
   Google Scholar
• Marley E. Pharmacological Studies. Studies in Psychiatry, M. Shepherd, D. L. Davies. O.U.P., London 1968
   Google Scholar
• McLeod W. R. University of Melbourne. 1970, Unpublished M.D. Thesis
   Google Scholar
• Oates J. A., Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960; 10: 1076
   PubMed Web of Science ®Google Scholar
• Page I. R. Serotonin U.S.A. Year Book Medical Publishers Inc., Chicago 1968
   Google Scholar
• Pare C. M. Potentiation of MAOI's by tryptophan. Lancet 1963; 2: 527
   PubMed Web of Science ®Google Scholar
• Pare C. M., Yeung D. D., Price K., Stacey R. S. 5-HT, NA, and dopamine in brainstem, hypothalamus and caudate nucleus of controls and of patients committing suicide by coalgas poisoning. Lancet 1969; 2: 133
   PubMedGoogle Scholar
• Poschel B. P., Ninteman P. W. Life Science, Part I 1968; 7: 317
   PubMedGoogle Scholar
• Pletscher A., Brossi A., Gey K. F. International Review of Neurobiology, C. C. Pfeiffer, J. R. Smythies. Academic Press, New York 1962
   Google Scholar
• Roos B. E., Sjostrom R. 5-HIAA (and HVA) levels in cerebro-spinal fluid after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin. 1969; 1: 1
   Google Scholar
• Shaw D. M., Camps P. E., Eccleston E. P. 5-hydroxytryptamine in hind-brains of depressive suicides. Brit. J. Psychiat. 1967; 113: 1307
   Google Scholar
• Takagi H., Satoia M., Yamatsu K., Kumura A., Nakama M. Central effects of 3, 4 DOPA and 5-HT on tetrabenazine pre-treated rabbits with special reference to the possible role of catecholamine and serotonin in the brain. Int. J. Neuropharmacol. 1968; 7: 272
   Google Scholar
• Vogt M. Advances in pharmacology. Recent Advances in Pharmacology, S. Garattini, P. A. Shore. Academic Press, New York 1968
   Google Scholar